Literature DB >> 24161194

Cardiovascular risk and psoriasis: beyond the traditional risk factors.

Ann G Coumbe1, Marc R Pritzker1, Daniel A Duprez2.   

Abstract

Psoriasis is an autoimmune disease resulting in plaques of the skin. Similar to atherosclerosis, inflammation is integral to the initiation and propagation of plaque development. Mounting evidence has emerged demonstrating that psoriasis not only is associated with increased prevalence of cardiovascular risk factors, but also is an independent risk factor for the development of cardiovascular disease. Systemic therapies for moderate to severe psoriasis can increase the cardiovascular risk. Despite the evidence that psoriasis is an independent risk factor for cardiovascular disease, current guidelines only address managing traditional risk factors. An interdisciplinary approach is needed to find the necessary steps beyond classic risk reduction and detection of early cardiovascular disease in patients with psoriasis, as well as to develop a cardiovascular disease preventive regimen.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular disease; Cardiovascular risk; Inflammation; Prevention; Psoriasis

Mesh:

Year:  2013        PMID: 24161194     DOI: 10.1016/j.amjmed.2013.08.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  The peptide lycosin-I attenuates TNF-α-induced inflammation in human umbilical vein endothelial cells via IκB/NF-κB signaling pathway.

Authors:  Xianyao Li; Yaqin Tang; Binbin Ma; Zheng Wang; Jinying Jiang; Shengjie Hou; Shuhang Wang; Jie Zhang; Meichun Deng; Zhigui Duan; Xing Tang; Alex F Chen; Liping Jiang
Journal:  Inflamm Res       Date:  2018-03-10       Impact factor: 4.575

Review 2.  The association between platelet indices and presence and severity of psoriasis: a systematic review and meta-analysis.

Authors:  Z Liu; L A Perry; V Morgan
Journal:  Clin Exp Med       Date:  2022-04-04       Impact factor: 3.984

Review 3.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

Review 4.  The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

Authors:  Camille Roubille; Vincent Richer; Tara Starnino; Collette McCourt; Alexandra McFarlane; Patrick Fleming; Stephanie Siu; John Kraft; Charles Lynde; Janet Pope; Wayne Gulliver; Stephanie Keeling; Jan Dutz; Louis Bessette; Robert Bissonnette; Boulos Haraoui
Journal:  Ann Rheum Dis       Date:  2015-01-05       Impact factor: 19.103

5.  Pseudomonas aeruginosa Microcolonies in Coronary Thrombi from Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Gorm Mørk Hansen; Daniel Belstrøm; Martin Nilsson; Steffen Helqvist; Claus Henrik Nielsen; Palle Holmstrup; Tim Tolker-Nielsen; Michael Givskov; Peter Riis Hansen
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

6.  The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.

Authors:  Patrick M Brunner; Mayte Suárez-Fariñas; Helen He; Kunal Malik; Huei-Chi Wen; Juana Gonzalez; Tom Chih-Chieh Chan; Yeriel Estrada; Xiuzhong Zheng; Saakshi Khattri; Annunziata Dattola; James G Krueger; Emma Guttman-Yassky
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

7.  IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.

Authors:  Michelle S M A Damen; Rabia Agca; Suzanne Holewijn; Jacqueline de Graaf; Jéssica C Dos Santos; Piet L van Riel; Jaap Fransen; Marieke J H Coenen; Mike T Nurmohamed; Mihai G Netea; Charles A Dinarello; Leo A B Joosten; Bas Heinhuis; Calin D Popa
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

Review 8.  Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

Authors:  Stephen Chu-Sung Hu; Cheng-Che E Lan
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

9.  Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.

Authors:  Simon Gerhardt; Veronika König; Monika Doll; Tsige Hailemariam-Jahn; Igor Hrgovic; Nadja Zöller; Roland Kaufmann; Stefan Kippenberger; Markus Meissner
Journal:  J Inflamm (Lond)       Date:  2015-08-06       Impact factor: 4.981

10.  Prevalence of metabolic syndrome in Chinese psoriasis patients: A hospital-based cross-sectional study.

Authors:  Xin-Yu Gui; Xiao-Ling Yu; Hong-Zhong Jin; Ya-Gang Zuo; Chao Wu
Journal:  J Diabetes Investig       Date:  2017-05-24       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.